Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein.
about
Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infectionUnexpected structural features of the hepatitis C virus envelope protein 2 ectodomain.Substitution at aspartic acid 1128 in the SARS coronavirus spike glycoprotein mediates escape from a S2 domain-targeting neutralizing monoclonal antibodyInhibition of arenavirus infection by a glycoprotein-derived peptide with a novel mechanism.Peptide inhibition of human cytomegalovirus infectionA fusion-inhibiting peptide against Rift Valley fever virus inhibits multiple, diverse viruses.Identification of Peptide Inhibitors of Enveloped Viruses Using Support Vector Machine.Chronic beta-AR activation-induced calpain activation and impaired eNOS-Akt signaling mediates cardiac injury in ovariectomized female rats.Aromatic amino acids in the juxtamembrane domain of severe acute respiratory syndrome coronavirus spike glycoprotein are important for receptor-dependent virus entry and cell-cell fusion.Effects of HIV-1 gp41-Derived Virucidal Peptides on Virus-like Lipid Membranes.The pre-transmembrane domain of the Autographa californica multicapsid nucleopolyhedrovirus GP64 protein is critical for membrane fusion and virus infectivity.Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome: Current Therapeutic Options and Potential Targets for Novel Therapies.Interaction of a peptide corresponding to the loop domain of the S2 SARS-CoV virus protein with model membranes.Peptides as Therapeutic Agents for Dengue Virus.
P2860
Q28383088-CC4DB2D6-B655-4E41-BB8B-2BECC1C7921CQ30364309-93675EB6-CB05-4B59-99D1-0939592BBBD9Q33897964-459847DB-80CF-47F9-82CD-8AC84D83C524Q34057832-BFAF5337-1873-450C-A91B-8CBDF368AE10Q34633529-0AC6E78D-ACEC-43E3-A0A5-3E531A5C1F54Q34999859-DC407950-A115-4968-BF98-D98449575C17Q35860797-8E91BED4-EEF0-493E-A316-4AF77D25F07FQ37486435-01B09ECF-4075-4777-ACCD-AA2950C13BFEQ38294473-0A964F55-3F93-4CB7-9A9A-16E598119B5AQ38630012-9155CEF1-FDB6-4BEE-9CB4-DAFF2A0E7DA9Q39810765-DF244C23-1B8F-4CF5-9AC0-1FF5D3648DB5Q43280688-76649515-23CC-423F-8202-5BAA9FE988F9Q43520298-4099CA78-707F-4B22-B3C6-07F3AAA470A4Q45323856-C98E9545-D5B1-47DF-B7CB-570F523A8ACD
P2860
Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Inhibition of severe acute res ...... us to the viral spike protein.
@en
type
label
Inhibition of severe acute res ...... us to the viral spike protein.
@en
prefLabel
Inhibition of severe acute res ...... us to the viral spike protein.
@en
P2093
P2860
P1433
P1476
Inhibition of severe acute res ...... us to the viral spike protein.
@en
P2093
Bruno Sainz
C J Peters
Eric C Mossel
Russell B Wilson
William C Wimley
William R Gallaher
P2860
P304
P356
10.1016/J.VIRUSRES.2006.03.001
P577
2006-04-17T00:00:00Z